DanCann Pharma A/S
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.441988 USD
−1.16 M USD
1.02 M USD
2.68 M
About DanCann Pharma A/S
Sector
Industry
CEO
Jeppe Krog Rasmussen
Website
Headquarters
Ansager
Founded
2018
Identifiers
2
ISIN DK0063631999
DanCann Pharma A/S is a biopharmaceutical company, which engages in the business of discovering, developing, manufacturing, and commercializing new therapeutic cannabinoids in various disease areas. It operates under the Biomaterials and Import and Export of Medical Cannabis Products segments. The company was founded by Jeppe Krog Rasmussen on March 20, 2018 and is headquartered in Ansager, Denmark.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange DanCann Pharma A/S stocks are traded under the ticker DCPXF.
DCPXF reached its all-time high on Jan 4, 2024 with the price of 0.010000 USD, and its all-time low was 0.010000 USD and was reached on Jan 4, 2024. View more price dynamics on DCPXF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DCPXF stock is 0.00% volatile and has beta coefficient of 0.40. Track DanCann Pharma A/S stock price on the chart and check out the list of the most volatile stocks — is DanCann Pharma A/S there?
Today DanCann Pharma A/S has the market capitalization of 88.56 K, it has decreased by −11.19% over the last week.
Yes, you can track DanCann Pharma A/S financials in yearly and quarterly reports right on TradingView.
DanCann Pharma A/S is going to release the next earnings report on Mar 4, 2026. Keep track of upcoming events with our Earnings Calendar.
DCPXF net income for the last quarter is −244.92 K USD, while the quarter before that showed −436.21 K USD of net income which accounts for 43.85% change. Track more DanCann Pharma A/S financial stats to get the full picture.
No, DCPXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DanCann Pharma A/S EBITDA is −1.13 M USD, and current EBITDA margin is −70.13%. See more stats in DanCann Pharma A/S financial statements.
Like other stocks, DCPXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DanCann Pharma A/S stock right from TradingView charts — choose your broker and connect to your account.